Literature DB >> 30530612

Bone health after diagnosis of breast cancer.

Shannon M Ruzycki1, Nancy A Nixon2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30530612      PMCID: PMC6279453          DOI: 10.1503/cmaj.180802

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

2.  The occurrence of fractures after adjuvant treatment of breast cancer: a DBCG register study.

Authors:  Bent Kristensen; Bent Ejlertsen; Maj-Britt Jensen; Henning T Mouridsen
Journal:  Acta Oncol       Date:  2017-11-23       Impact factor: 4.089

3.  Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art.

Authors:  M Clemons; K A Gelmon; K I Pritchard; A H G Paterson
Journal:  Curr Oncol       Date:  2012-10       Impact factor: 3.677

4.  Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials.

Authors:  A Lipton; R L Theriault; G N Hortobagyi; J Simeone; R D Knight; K Mellars; D J Reitsma; M Heffernan; J J Seaman
Journal:  Cancer       Date:  2000-03-01       Impact factor: 6.860

5.  Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Authors: 
Journal:  Lancet       Date:  2015-07-23       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.